Last week saw the newest annual earnings release from Mister Spex SE , an important milestone in the company's journey to build a stronger business. Revenues were in line with exp ...

Marex Group PLC (MRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). ENS, IBCP and MRX made it to the Zacks ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

At close: 4:00:01 p.m. EDT ...

根据AI大模型测算盟科药业后市走势。短期趋势看，该股当前无连续增减仓现象，主力趋势不明显。主力没有控盘。中期趋势方面，下方累积一定获利筹码。近期该股有吸筹现象，但吸筹力度不强。舆情分析来看，2家机构预测目标均价5.20，低于当前价-13.19%。目前市场情绪中性。

截至3月25日收盘，盟科药业报5.68元，下跌0.87%，成交867.62万股，成交量连续3个交易日缩量，缩量区间跌幅4.7%。 资料显示，上海盟科药业股份有限公司的主营业务是小分子化药研发。公司的主要产品是MRX-1康替唑胺片、MRX-4康替唑胺片、MRX-8康替唑胺片、MRX-5康替唑胺片。

北京时间3月29日19点35分，中超联赛第3轮焦点大战，北京国安将在主场迎战成都蓉城。赛前，据博主“国安工体是冠军”透露，已有1600多个来自四川的身份证购票记录。博主“国安工体是冠军”表示：“这场北京vs成都的主场球票数据中，有1600多个来自四川 ...

Get ahead with Seeking Alpha’s Catalyst Watch. Explore next week's events like IPOs, earnings, and Fed updates poised to ...

The initial partnership with BMLL provided a competitive advantage to quantitative traders by enabling them to take granular, ...